|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cardiovascular Diseases | |||||
| 2 | Interventions listed in this trial | ||||
| Positron Emission Tomography (PET) | |||||
| L-NAME | |||||
| L-Arginine | |||||
| Phenylephrine | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| NG-Nitroarginine Methyl Ester | |||||
| Nitric Oxide | |||||
| 4 | More general drug interventions related to this trial | ||||
| Adrenergic Agents | |||||
| Adrenergic Agonists | |||||
| Adrenergic alpha-Agonists | |||||
| Anti-Asthmatic Agents | |||||
| Antioxidants | |||||
| Autonomic Agents | |||||
| Bronchodilator Agents | |||||
| Cardiotonic Agents | |||||
| Cardiovascular Agents | |||||
| Endothelium-Dependent Relaxing Factors | |||||
| Enzyme Inhibitors | |||||
| Free Radical Scavengers | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Mydriatics | |||||
| Nasal Decongestants | |||||
| Neurotransmitter Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Respiratory System Agents | |||||
| Sympathomimetics | |||||
| Therapeutic Uses | |||||
| Vasoconstrictor Agents | |||||
| Vasodilator Agents | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute on Aging (NIA) | |||||